Shandong Weigao Group Medical Polymer Co's quarterly market cap
declined
from Dec. 2022 ($7,267 Mil) to Jun. 2023 ($5,936 Mil) and
declined
from Jun. 2023 ($5,936 Mil) to Dec. 2023 ($4,399 Mil).
Shandong Weigao Group Medical Polymer Co's annual market cap
increased
from Dec. 2021 ($5,845 Mil) to Dec. 2022 ($7,267 Mil) but then
declined
from Dec. 2022 ($7,267 Mil) to Dec. 2023 ($4,349 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shandong Weigao Group Medical Polymer Co's Enterprise Value for Today is $2,781 Mil.
Shandong Weigao Group Medical Polymer Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shandong Weigao Group Medical Polymer Co Market Cap Chart
Shandong Weigao Group Medical Polymer Co Annual Data
Competitive Comparison of Shandong Weigao Group Medical Polymer Co's Market Cap
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Market Cap falls into.
Shandong Weigao Group Medical Polymer Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Shandong Weigao Group Medical Polymer Co Market Cap Related Terms
Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHWGY has been successfully added to your 